Ceritinib targets and binds to the ALK protein, which is abnormally activated in certain types of cancer. By inhibiting this protein, ceritinib disrupts the signaling pathways that promote cancer cell proliferation and survival. This helps to slow down or stop the progression of the cancer and can lead to tumor shrinkage.
